Adrian J Fretland

3PUBLICATIONS
28CO-AUTHORS
Molecular targetsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results.

Ezra Y Rosen, Timothy A Yap, Elisa Fontana

|Dec 11, 2023
Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib.

Ezra Rosen, Timothy A Yap, Elizabeth K Lee

|Jun 05, 2023
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.

Timothy A Yap, Elisa Fontana, Elizabeth K Lee

Pageof 1